Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03913702 · ClinicalTrials.gov registry record · Phase 2
Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement
A Phase 2 study, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT03913702: Clinical Trial Phase 2 study, sponsored by The University of Texas Medical Branch, Galveston.
NCT03913702 is a Phase 2 study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 1 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03913702, a Phase 2 study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The investigators aim to compare subacromial ketorolac (non-steroidal anti-inflammatory drug) versus methylprednisolone (steroid) for the treatment of shoulder impingement syndrome.
Primary Outcome
The ASES is a self-assessment score, ranging between 0 and 100 (0 indicating the worst shoulder condition and 100 indicating the best shoulder condition), applicable for use in patients with shoulder pathology. A higher pain score indicates the subject is in more pain. A lower pain score indicates less pain.
Interventions
- DRUG Ketorolac Tromethamine
- DRUG Methylprednisolone Acetate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-09-09 |
| Est. Completion | 2022-11-02 |
| Phase | Phase 2 |
Why NCT03913702 stopped before completion
NCT03913702 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Ketorolac Tromethamine is the first listed.
NCT03913702 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03913702 about?
NCT03913702 is a clinical study titled "Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement". The investigators aim to compare subacromial ketorolac (non-steroidal anti-inflammatory drug) versus methylprednisolone (steroid) for the treatment of shoulder impingement syndrome.
What is the current status of trial NCT03913702?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2019-09-09. Estimated completion is 2022-11-02.
What interventions are being tested in trial NCT03913702?
The interventions under investigation include: Ketorolac Tromethamine (DRUG), Methylprednisolone Acetate (DRUG).
Who is sponsoring clinical trial NCT03913702?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03913702's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI